Target intelligence / Profile preview

Platelet Protease-Activated Receptor (PAR)

Target
PAR
Molecular classification
G-protein-coupled receptor (GPCR), Receptor, Protease-activated receptor, Class A GPCR
01

Overview

Platelet protease-activated receptors (PARs) are a family of G-protein-coupled receptors (GPCRs) that play a central role in platelet activation, aggregation, and the regulation of hemostasis and thrombosis. The main subtypes in human platelets are PAR1 and PAR4, both activated by thrombin. Activation involves proteolytic cleavage by serine proteases, exposure of a tethered ligand, and intramolecular binding to initiate intracellular signaling. PAR1 is a high-affinity thrombin receptor mediating rapid platelet responses, while PAR4 has lower affinity and mediates slower, sustained responses. PARs are therapeutic targets for antithrombotic therapy.

Other names
Protease-Activated ReceptorPAR1PAR4
02

Mechanism of action

Inhibition of platelet activation by blocking protease-mediated receptor cleavage and activation, or by blocking the tethered ligand binding site.

03

Biological functions

Platelet activationPlatelet aggregationHemostasisThrombosisSignal transduction
04

Disease associations

Thrombotic disordersCardiovascular disease
05

Safety considerations

Bleeding risk associated with antiplatelet therapiesSpecies differences in receptor expression may affect translational research
06

Interacting drugs

PAR1 antagonists

2 more in the full profile.

Beyond the preview

Go deeper on Platelet Protease-Activated Receptor (PAR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Platelet Protease-Activated Receptor (PAR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call